Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 8/20 | 0.52 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.43 |
| ▸ | SELP | P16109 | 2/20 | 0.41 |
| ▸ | SELL | P14151 | 2/20 | 0.41 |
| ▸ | MAG | P20916 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12903200 | 0.94 | SELE (0.58) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL17903250 | 0.91 | SELE (0.59) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL17903028 | 0.87 | SIGLEC7 (0.54) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL17903026 | 0.86 | SELE (0.49) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL18211305 | 0.85 | SELE (0.66) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL17903219 | 0.82 | SIGLEC7 (0.53) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL12903205 | 0.82 | SELE (0.55) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL17903216 | 0.82 | SELE (0.49) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL12903201 | 0.81 | SELE (0.57) | SELESIGLEC7SELPSELLMAG | |
| SCHEMBL12903206 | 0.80 | SIGLEC7 (0.60) | SELESIGLEC7SELPSELLMAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160193294-A1 | COMPOSITIONS COMPRISING E-SELECTIN ANTAGONISTS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160193294-A1 | COMPOSITIONS COMPRISING E-SELECTIN ANTAGONISTS AND USES THEREFOR | SELL, SELP, SELE | SELE 3/4885SIGLEC7 9/4885SELP 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.